MENU
SYRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Spyre Therapeutics (SYRE) Ownership - Who owns Spyre Therapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
30
Web
https://www.spyre.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.61B
P/E Ratio
1.84
Total Cash
2.96M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
4.01
Dividend Yield
N/A
Total Cash/Share
0.06
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SYRE
Capitalization
1.61B
P/E Ratio
1.84
Risk (Beta)
4.01
Dividend Yield
N/A
Total Cash
2.96M
Total Cash/Share
0.06
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
-32.66M
P/B Ratio
9.37
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
11.38
Current Revenue Per Employee
49142.86
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
1.77B
Shares Outstanding - Current
51.4M
Total Liabilities
81.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
45.307
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
30
Web
https://www.spyre.com